<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="P0b002ee1d19e3c63">
    <name type="corporate">
         <namePart>United States Government Publishing Office</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
              <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
         <role>
              <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
              <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">author</roleTerm>
              <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
         <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
         <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
         <collectionCode>BILLS</collectionCode>
         <searchTitle>To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.;Old Drugs, New Cures Act;H.R. 2542 (IH)
    </searchTitle>
         <category>Bills and Statutes</category>
         <waisDatabaseName>119_cong_bills</waisDatabaseName>
         <branch>legislative</branch>
         <dateIngested>2025-04-08</dateIngested>
    </extension>
    <titleInfo>
         <title>To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>Old Drugs, New Cures Act</title>
    </titleInfo>
    <titleInfo type="alternative">
         <title>H.R. 2542 (IH)
    </title>
    </titleInfo>
    <originInfo>
         <publisher>U.S. Government Publishing Office</publisher>
         <dateIssued encoding="w3cdtf">2025-04-01</dateIssued>
         <issuance>monographic</issuance>
    </originInfo>
    <physicalDescription>
         <note type="source content type">deposited</note>
         <digitalOrigin>born digital</digitalOrigin>
         <extent>5 p.</extent>
    </physicalDescription>
    <classification authority="sudocs">Y 1.6:</classification>
    <classification authority="sudocs">Y 1.4/6:</classification>
    <identifier type="local">P0b002ee1d19e3c63</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/BILLS-119hr2542ih</identifier>
    <identifier type="preferred citation">H.R. 2542</identifier>
    <identifier type="stock number">021-610-00252-9</identifier>
    <identifier type="Parent ILS system id">000501532</identifier>
    <identifier type="Child ILS system id">000325573</identifier>
    <identifier type="Parent ILS title">Congressional bills</identifier>
    <identifier type="Child ILS title">House bills</identifier>
    <identifier type="former package identifier">f:h2542_ih.txt</identifier>
    <location>
         <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/BILLS-119hr2542ih</url>
         <url displayLabel="HTML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr2542ih/html/BILLS-119hr2542ih.htm</url>
         <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr2542ih/pdf/BILLS-119hr2542ih.pdf</url>
         <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/BILLS-119hr2542ih/xml/BILLS-119hr2542ih.xml</url>
    </location>
    <accessCondition type="GPO scope determination">fdlp</accessCondition>
    <recordInfo>
         <recordContentSource authority="marcorg">DGPO</recordContentSource>
         <recordCreationDate encoding="w3cdtf">2025-04-08</recordCreationDate>
         <recordChangeDate encoding="w3cdtf">2025-04-08</recordChangeDate>
         <recordIdentifier source="DGPO">BILLS-119hr2542ih</recordIdentifier>
         <recordOrigin>machine generated</recordOrigin>
         <languageOfCataloging>
              <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
        </languageOfCataloging>
    </recordInfo>
    <name type="personal">
         <namePart>Donald G. Davis</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm authority="marcrelator" type="text">sponsor</roleTerm>
              <roleTerm authority="marcrelator" type="code">spn</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="personal">
         <namePart>August Pfluger</namePart>
         <affiliation>United States House of Representatives</affiliation>
         <role>
              <roleTerm type="text">cosponsor</roleTerm>
        </role>
         <description>United States Congress Member</description>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on Energy and Commerce</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <name type="corporate">
         <namePart>United States</namePart>
         <namePart>Congress</namePart>
         <namePart>House of Representatives</namePart>
         <namePart>Committee on Ways and Means</namePart>
         <role>
              <roleTerm authority="marcrelator" type="text">associated name</roleTerm>
              <roleTerm authority="marcrelator" type="code">asn</roleTerm>
        </role>
    </name>
    <relatedItem type="isReferencedBy">
         <titleInfo>
              <title>United States Code</title>
              <partNumber>Title 42 Section 1395w-114b(b)(5)(B)(ii)</partNumber>
              <partNumber>Title 42 Section 1396r-8(c)(1)(C)(ii)(V)</partNumber>
              <partNumber>Title 42 Section 1396r-8(c)(2)(C)</partNumber>
              <partNumber>Title 42 Section 256b</partNumber>
        </titleInfo>
         <identifier type="USC citation">42 U.S.C. 1395w-114b(b)(5)(B)(ii)</identifier>
         <identifier type="USC citation">42 U.S.C. 1396r-8(c)(1)(C)(ii)(V)</identifier>
         <identifier type="USC citation">42 U.S.C. 1396r-8(c)(2)(C)</identifier>
         <identifier type="USC citation">42 U.S.C. 256b</identifier>
    </relatedItem>
    <extension>
         <docClass>hr</docClass>
         <accessId>BILLS-119hr2542ih</accessId>
         <congress>119</congress>
         <session>1</session>
         <originChamber>HOUSE</originChamber>
         <currentChamber>HOUSE</currentChamber>
         <billNumber>2542</billNumber>
         <billVersion reprint="false">ih</billVersion>
         <fileSuffix>ih</fileSuffix>
         <shortTitle type="measure">Old Drugs, New Cures Act</shortTitle>
         <officialTitle>To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.</officialTitle>
         <action date="2025-04-01">Mr. Davis of North Carolina (for himself and Mr. Pfluger) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action>
         <congCommittee authorityId="hsif00" chamber="H" congress="119" type="S">
                                
              <name type="authority-standard">Committee on Energy and Commerce</name>
                                
              <name type="authority-short">Energy and Commerce</name>
                            
        </congCommittee>
         <congCommittee authorityId="hswm00" chamber="H" congress="119" type="S">
                                
              <name type="authority-standard">Committee on Ways and Means</name>
                                
              <name type="authority-short">Ways and Means</name>
                            
        </congCommittee>
         <congMember bioGuideId="D000230" chamber="H" congress="119" party="D" role="SPONSOR" state="NC">
                                
              <name type="parsed">Mr. Davis of North Carolina</name>
                                
              <name type="authority-fnf">Donald G. Davis</name>
                                
              <name type="authority-lnf">Davis, Donald G.</name>
                                
              <name type="authority-other">Mr. Donald Davis</name>
                            
        </congMember>
         <congMember bioGuideId="P000048" chamber="H" congress="119" party="R" role="COSPONSOR" state="TX">
                                
              <name type="parsed">Mr. Pfluger</name>
                                
              <name type="authority-fnf">August Pfluger</name>
                                
              <name type="authority-lnf">Pfluger, August</name>
                            
        </congMember>
         <isPrivate>false</isPrivate>
         <isAppropriation>false</isAppropriation>
         <USCode title="42">
                                
              <section detail="(b)(5)(B)(ii)" number="1395w-114b"></section>
                                
              <section detail="(c)(1)(C)(ii)(V)" number="1396r-8"></section>
                                
              <section detail="(c)(2)(C)" number="1396r-8"></section>
                                
              <section number="256b"></section>
                            
        </USCode>
    </extension>
</mods>